KSI-101
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for KSI-101, covering 2025-09-10 to 2025-09-12. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PINNACLE [Phase 3]